RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.
Use of e-health increases but not always effective 2021 saw an increase in the use of e-health in every part of the healthcare industry in comparison with 2019. There were several reasons for this, including the coronavirus pandemic.
International research confirms: lockdowns have negative impact on many young people Lockdowns have a negative impact on the physical and mental health of many young people. They get less exercise and experience more feelings of depression, loneliness and insecurity.
Nature Nanotechnology publishes RIVM research on plastics On Thursday 20 January, Nature Nanotechnology published the article Quantitative tracing of uptake and transport of submicrometre plastics in crop plants using lanthanide chelates as a dual-functional tracer.
RIVM study confirms: Tata Steel site is main source of PAHs and metals in the IJmond region A new study conducted by RIVM shows that the PAHs and metals present in the living environment of residents of the IJmond region predominantly originate from the Tata Steel site.
Quality of protective equipment insufficient during COVID-19 crisis The personal protective equipment (PPE) purchased at the national level during the COVID-19 crisis for use in the healthcare sector only partly met the required standards of quality.
Nearly a quarter-million positive COVID-19 tests last week Last week*, 242,961 positive COVID-19 tests were reported to RIVM**. That is an increase of 21% compared to the week before that.
Women have a better memory than men in middle age, but decline faster Middle-aged women have a better memory than men. They also process information faster than men. In the years that follow, however, both cognitive functions decline faster in women. This has been shown by research conducted by RIVM and VU Amsterdam.
COVID-19 vaccination for children aged 5-11 years possible as of 18 January Starting on 18 January 2022, parents of children aged 5-11 years will receive a letter with information about COVID-19 vaccination for their child or children.
200 thousand people tested positive in one week 201,536 positive COVID-19 tests were reported to RIVM last week. That is an increase of 77% compared to the previous week. Such high numbers of reported infections within just one week have never been seen before in the Netherlands.